Immunization and Liver Transplantation

Jessica Hause, Erin Spengler

Producción científica: Chapter

Resumen

Vaccine-preventable illnesses are a source of considerable morbidity and mortality in liver transplant recipients. Nearly all liver transplant recipients require life-long immunosuppression, significantly increasing their risk of infections. The primary strategy for immunizing liver transplant recipients is to deliver all vaccines prior to liver transplantation. Liver transplant candidates are more likely to develop vaccine-induced immunity compared to transplant recipients receiving immunosuppression. Measles, mumps, and rubella vaccination is usually given in childhood, and together, although some individual vaccines are available. Induction immunosuppression in liver transplant recipients could result in ineffective vaccine response in the early post-transplant period. Hepatitis A vaccination should be offered to all patients with chronic liver disease. It is strongly recommended that members of the transplant care team be vaccinated against transmissible infections, such as measles, mumps, rubella, hepatitis B, and varicella zoster. All healthcare workers should also receive an annual influenza vaccine.

Idioma originalEnglish (US)
Título de la publicación alojadaLiver Transplantation
Subtítulo de la publicación alojadaClinical Assessment and Management: Second Edition
Editorialwiley
Páginas525-528
Número de páginas4
ISBN (versión digital)9781119634010
ISBN (versión impresa)9781119633983
DOI
EstadoPublished - ene 1 2021
Publicado de forma externa

ASJC Scopus subject areas

  • General Medicine

Huella

Profundice en los temas de investigación de 'Immunization and Liver Transplantation'. En conjunto forman una huella única.

Citar esto